Cause of Death During Long-Term Follow-up for Superficial Esophageal Adenocarcinoma

被引:9
作者
Kauppi, Juha [1 ]
Gockel, Ines [2 ]
Rantanen, Tuomo [1 ]
Hansen, Torsten [3 ]
Ristimaki, Ari [4 ,5 ,6 ]
Lang, Hauke [2 ]
Sihvo, Eero [1 ]
Rasanen, Jari [1 ]
Junginger, Theodor [2 ]
Salo, Jarmo A. [1 ]
机构
[1] Helsinki Univ Cent Hosp, Heart & Lung Ctr, Clin Gen Thorac & Esophageal Surg, Helsinki, Finland
[2] Univ Med Ctr, Dept Gen & Abdominal Surg, Mainz, Germany
[3] Univ Med Ctr, Inst Pathol, Mainz, Germany
[4] Helsinki Univ Cent Hosp, HUSLAB, Dept Pathol, Helsinki, Finland
[5] Univ Helsinki, Haartman Inst, Helsinki, Finland
[6] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland
关键词
LYMPH-NODE METASTASIS; LIMITED TRANSHIATAL RESECTION; ESOPHAGOGASTRIC JUNCTION; BARRETTS-ESOPHAGUS; SURGICAL-TREATMENT; PROGNOSTIC-FACTORS; CANCER; CARCINOMA; SURVIVAL; PREDICTION;
D O I
10.1245/s10434-013-2866-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to evaluate long-term prognosis and cause of death in patients with superficial esophageal adenocarcinoma (SEAC) after surgery. A total of 85 patients without adjuvant or neoadjuvant treatment underwent surgery for SEAC (pT1N0-1, M0) 1984-2011. Medical records and causes of death were reviewed, and 79 specimens (93 %) were reanalyzed for cancer penetration. Survival was calculated according to Kaplan-Meier and comparisons of survival with log-rank test. Multivariate survival was analyzed with Cox proportional hazards model. Of 85 patients, 36 had transhiatal, 33 transthoracic en bloc, 6 minimally invasive en bloc, 5 vagal sparing esophageal resection and 5 endoscopic mucosal resections; 7 patients (8 %) had lymph node metastasis (LNM). Cancer penetration: 35 pT1a and 44 pT1b. Overall survival was 67 % at 5 years and 50 % at 10 years. Disease-specific survival was 82 % at 5 years and 78 % at 10 years. Recurrence-free survival was 80 % at 5 years. In a Cox multivariate model, poor overall survival was predicted only by LNM. Cumulative mortality during median follow-up of 5 years (0-25 years): 37 of 85 (44 %). Cause of death of these 37: SEAC recurrence for 15 (41 %), postoperative complications for 4 (11 %), another primary malignancy for 5 (14 %), non-cancer-related for 11 (30 %) and for 2 (5 %) cause unknown. Mortality after 5-year follow-up: 11 (30 %); 82 % of these deaths were unrelated to SEAC recurrence. With SEAC recurrence as the single most common cause of death, disease-specific 5-year survival was good. Overall and late (> 5-year) survival is affected by diseases related to aging.
引用
收藏
页码:2428 / 2433
页数:6
相关论文
共 34 条
[1]   Prediction of Lymph Node Status in Superficial Esophageal Carcinoma [J].
Ancona, Ermanno ;
Rampado, Sabrina ;
Cassaro, Mauro ;
Battaglia, Giorgio ;
Ruol, Alberto ;
Castoro, Carlo ;
Portale, Giuseppe ;
Cavallin, Francesco ;
Rugge, Massimo .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (11) :3278-3288
[2]   Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process [J].
Bennett, Cathy ;
Vakil, Nimish ;
Bergman, Jacques ;
Harrison, Rebecca ;
Odze, Robert ;
Vieth, Michael ;
Sanders, Scott ;
Gay, Laura ;
Pech, Oliver ;
Longcroft-Wheaton, Gaius ;
Romero, Yvonne ;
Inadomi, John ;
Tack, Jan ;
Corley, Douglas A. ;
Manner, Hendrik ;
Green, Susi ;
Al Dulaimi, David ;
Ali, Haythem ;
Allum, Bill ;
Anderson, Mark ;
Curtis, Howard ;
Falk, Gary ;
Fennerty, M. Brian ;
Fullarton, Grant ;
Krishnadath, Kausilia ;
Meltzer, Stephen J. ;
Armstrong, David ;
Ganz, Robert ;
Cengia, Gianpaolo ;
Going, James J. ;
Goldblum, John ;
Gordon, Charles ;
Grabsch, Heike ;
Haigh, Chris ;
Hongo, Michio ;
Johnston, David ;
Forbes-Young, Ricky ;
Kay, Elaine ;
Kaye, Philip ;
Lerut, Toni ;
Lovat, Laurence B. ;
Lundell, Lars ;
Mairs, Philip ;
Shimoda, Tadakuza ;
Spechler, Stuart ;
Sontag, Stephen ;
Malfertheiner, Peter ;
Murray, Iain ;
Nanji, Manoj ;
Poller, David .
GASTROENTEROLOGY, 2012, 143 (02) :336-346
[3]   High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas [J].
Bollschweiler, E ;
Baidus, SE ;
Schröder, W ;
Prenzel, K ;
Gutschow, C ;
Schneider, PM ;
Hölscher, AH .
ENDOSCOPY, 2006, 38 (02) :149-156
[4]   Changes in Age, Stage Distribution, and Survival of Patients with Esophageal Adenocarcinoma over Three Decades in the United States [J].
Cen, Putao ;
Banki, Farzaneh ;
Cheng, Lee ;
Khalil, Kamal ;
Du, Xianglin L. ;
Fallon, Michael ;
Amato, Robert J. ;
Kaiser, Larry R. .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (05) :1685-1691
[5]  
Christein JD, 2002, AM SURGEON, V68, P258
[6]   Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management [J].
Dent, John .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 :11-30
[7]  
Gen P, 2008, CANCER-AM CANCER SOC, V112, P1020, DOI [10.1002/cncr23265, 10.1002/cncr.23265]
[8]   Prediction Model of Lymph Node Metastasis in Superficial Esophageal Adenocarcinoma and Squamous Cell Cancer Including D2-40 Immunostaining [J].
Gockel, I. ;
Domeyer, M. ;
Sgourakis, G. G. ;
Schimanski, C. C. ;
Moehler, M. ;
Kirkpatrick, C. J. ;
Lang, H. ;
Junginger, Th. ;
Hansen, T. .
JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (03) :191-198
[9]  
HOLSCHER AH, 1995, CANCER-AM CANCER SOC, V76, P178, DOI 10.1002/1097-0142(19950715)76:2<178::AID-CNCR2820760204>3.0.CO
[10]  
2-D